UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Population differences in microRNA expression and biological implications

RNA biology, 2011-07, Vol.8 (4), p.692-701

2011

Volltextzugriff (PDF)

A Genome-Wide Approach to Identify Genetic Variants That Contribute to Etoposide-Induced Cytotoxicity

Proceedings of the National Academy of Sciences - PNAS, 2007-06, Vol.104 (23), p.9758-9763

2007

Volltextzugriff (PDF)

Genetic Architecture of Transcript-Level Variation in Humans

American journal of human genetics, 2008-05, Vol.82 (5), p.1101-1113

2008

Volltextzugriff (PDF)

Genetic variants contributing to daunorubicin-induced cytotoxicity

Cancer research (Chicago, Ill.), 2008-05, Vol.68 (9), p.3161-3168

2008

Volltextzugriff (PDF)

Effect of population and gender on chemotherapeutic agent-induced cytotoxicity

Molecular cancer therapeutics, 2007-01, Vol.6 (1), p.31-36

2007

Volltextzugriff (PDF)

Evaluation of Genetic Variation Contributing to Differences in Gene Expression between Populations

American journal of human genetics, 2008-03, Vol.82 (3), p.631-640

2008

Volltextzugriff (PDF)

Mapping genes that contribute to daunorubicin-induced cytotoxicity

Cancer research (Chicago, Ill.), 2007-06, Vol.67 (11), p.5425-5433

2007

Volltextzugriff (PDF)

Identification of common genetic variants that account for transcript isoform variation between human populations

Human genetics, 2009-02, Vol.125 (1), p.81-93

2009

Volltextzugriff (PDF)

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers

Human molecular genetics, 2012-04, Vol.21 (7), p.1470-1480

2012

Volltextzugriff (PDF)

Identification of genomic regions contributing to etoposide-induced cytotoxicity

Human genetics, 2009-03, Vol.125 (2), p.173-180

2009

Volltextzugriff (PDF)

Identification of genetic variants and gene expression relationships associated with pharmacogenes in humans

Pharmacogenetics and genomics, 2008-06, Vol.18 (6), p.545-549

2008

Volltextzugriff (PDF)

Gender-specific differences in expression in human lymphoblastoid cell lines

Pharmacogenetics and genomics, 2007-06, Vol.17 (6), p.447-450

2007

Volltextzugriff (PDF)

Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines

Pharmacogenomics, 2009-04, Vol.10 (4), p.549-563

2009

Volltextzugriff (PDF)

Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds

Cancer chemotherapy and pharmacology, 2009-04, Vol.63 (5), p.881-887

2009

Volltextzugriff (PDF)

Role of GADD34 in modulation of cisplatin cytotoxicity

Biochemical pharmacology, 2006-01, Vol.71 (3), p.239-247

2006

Volltextzugriff (PDF)

Abstract 4731: Population specific microRNA expression and biological implications

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4731-4731

2011

Volltextzugriff (PDF)

Etoposide Sensitivity Does Not Predict MLL Rearrangements or Risk of Therapy‐Related Acute Myeloid Leukemia

Clinical pharmacology and therapeutics, 2008-12, Vol.84 (6), p.691-697

2008

Volltextzugriff (PDF)

Evaluation of Genetic Variation Contributing to Differences in Gene Expression between Populations

American journal of human genetics, 2008-05, Vol.82 (5), p.1223-1223

2008

Volltextzugriff (PDF)

Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines Supplementary material

Pharmacogenomics, 2009-04, Vol.10 (4), p.549-563

2009

Volltextzugriff (PDF)

Etoposide Sensitivity Does Not Predict MLL Rearrangements or Risk of Therapy-Related Acute Myeloid Leukemia

Blood, 2007-11, Vol.110 (11), p.1829-1829

2007

Volltextzugriff (PDF)

Role of GADD34 in modulation of cisplatin cytotoxicity

Biochemical pharmacology, 2005, Vol.71 (3), p.239-247

2005

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Population differences in microRNA expression and biological implications

A Genome-Wide Approach to Identify Genetic Variants That Contribute to Etoposide-Induced Cytotoxicity

Genetic Architecture of Transcript-Level Variation in Humans

Genetic variants contributing to daunorubicin-induced cytotoxicity

Effect of population and gender on chemotherapeutic agent-induced cytotoxicity

Evaluation of Genetic Variation Contributing to Differences in Gene Expression between Populations

Mapping genes that contribute to daunorubicin-induced cytotoxicity

Identification of common genetic variants that account for transcript isoform variation between human populations

An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers

Identification of genomic regions contributing to etoposide-induced cytotoxicity

Identification of genetic variants and gene expression relationships associated with pharmacogenes in humans

Gender-specific differences in expression in human lymphoblastoid cell lines

Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines

Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds

Role of GADD34 in modulation of cisplatin cytotoxicity

Abstract 4731: Population specific microRNA expression and biological implications

Etoposide Sensitivity Does Not Predict MLL Rearrangements or Risk of Therapy‐Related Acute Myeloid Leukemia

Evaluation of Genetic Variation Contributing to Differences in Gene Expression between Populations

Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines Supplementary material

Etoposide Sensitivity Does Not Predict MLL Rearrangements or Risk of Therapy-Related Acute Myeloid Leukemia

Role of GADD34 in modulation of cisplatin cytotoxicity

Suchergebnisse filtern